Figure 3.
Responses of plasma apoCIII, remnant‐like particle cholesterol (RLP‐C) and triglyceride‐rich lipoprotein cholesterol (TRL‐C) after a fat‐rich mixed meal before treatment (open squares) and at week 16 (filled squares) in subjects with type 2 diabetes treated with liraglutide (n = 15) or placebo (n = 7). P values were calculated using the ANOVA repeated measures test for within‐group differences